Founded in 2005 as a spin-out from the University of Cambridge and MIT, Orthomimetics specializes in collagen biomaterials for scaffolds used in the repair of cartilage, meniscus, ligament, and tendon. Their CE-Mark approved product, Chondromimetic™, is an off-the-shelf implant for minimally invasive repair of small osteochondral defects. With a focus on the European market, Orthomimetics complements TiGenix' ChondroCelect® by targeting the same customer base in complementary indications.